Search clinical trials for: Dapagliflozin 5mg
Total 13435 results
-
Hospital Universitari Vall d'Hebron Research InstituteUnknownPostprandial HypoglycemiaSpain
-
Singapore General HospitalDuke-NUS Graduate Medical SchoolTerminatedDiabetic NephropathiesSingapore
-
NHS Greater Glasgow and ClydeUniversity of GlasgowCompletedHeart Failure | Diabetes MellitusUnited Kingdom
-
Nanjing University School of MedicineRecruiting
-
Monaldi HospitalRecruitingEfficacy | Systemic Right Ventricle | Dapagliflozin Adverse ReactionItaly
-
University of MilanNot yet recruiting
-
University of WashingtonAstraZenecaCompletedMyocardial Fibrosis | Type 2 Diabetes Mellitus | Myocardial InflammationUnited States
-
Hospices Civils de LyonWithdrawnEnd-stage Heart FailureFrance
-
AstraZenecaBristol-Myers SquibbCompletedType 1 Diabetes MellitusUnited States, Germany, Belgium, Canada, Japan, Chile, United Kingdom, Poland, Netherlands, Argentina, Sweden, Russian Federation, Switzerland
-
Consano Clinical Research, LLCCompletedDiabetes Mellitus, Type 2United States
-
TaiwanJ Pharmaceuticals Co., LtdTerminated
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 1Japan
-
Hannover Medical SchoolBoehringer IngelheimRecruitingAutosomal Dominant Polycystic KidneyGermany
-
Academisch Medisch Centrum - Universiteit van Amsterdam...ZonMw: The Netherlands Organisation for Health Research and DevelopmentRecruitingAcute Kidney Injury | Cardiac Surgery | Sodium-Glucose Transporter 2 InhibitorNetherlands
-
University of LeicesterAstraZeneca; Royal Surrey County Hospital NHS Foundation TrustCompletedThe Effect of a SGLT2 Inhibitor on Glucose Flux, Lipolysis and Exercise in Type 2 Diabetes (SINGLED)Type 2 DiabetesUnited Kingdom
-
Mansoura UniversityActive, not recruitingLupus Nephritis | SLE | SGLT2 InhibitorsEgypt
-
Steno Diabetes Center CopenhagenNovo Nordisk A/S; Glostrup University Hospital, CopenhagenCompletedHypoxia | Type 1 Diabetes | Nephropathy | Autonomic Neuropathy, Diabetic | Mitochondrial AlterationDenmark
-
Hamad Medical CorporationUnknownMyocardial Infarction | PreDiabetes | CVD | T2DM (Type 2 Diabetes Mellitus)Qatar
-
AstraZenecaBristol-Myers SquibbCompletedType 2 Diabetes Mellitus | Inadequate Glycaemic Control | High HbA1c LevelCzech Republic, Poland, Spain, Germany, Canada, Slovakia
-
Eisai Co., Ltd.Completed
-
Yale UniversityAstraZenecaNot yet recruitingBreast Cancer | Hyperinsulinism | HER2-negative Breast CancerUnited States
-
National Medical Research Center for Cardiology...RecruitingHeart Failure With Reduced Ejection Fraction | Heart Failure With Preserved Ejection Fraction | Heart Failure With Mid Range Ejection Fraction | Amyloid CardiomyopathyRussian Federation
-
Johns Hopkins UniversityUniversity of California, Los Angeles; AstraZeneca; Brett Boyer FoundationEnrolling by invitation
-
Medical University of ViennaAttoquant DiagnosticsCompletedDiabetes Mellitus, Type 2 | Diabetic Kidney Disease | Chronic Kidney Disease stage4 | Chronic Kidney Disease stage3Austria
-
AstraZenecaRecruitingChronic Kidney Disease With High ProteinuriaItaly, United States, Poland, Germany, Argentina, Denmark, Japan, Norway, Spain, Sweden, Bulgaria, France, China, Malaysia, Taiwan, Thailand, Vietnam, Brazil, Mexico, Philippines, Israel, United Kingdom, South Africa, Austria, Korea, Republic... and more
-
Albert Einstein Healthcare NetworkSuspendedAcute Kidney Injury | Percutaneous Coronary InterventionUnited States
-
Novo Nordisk A/SCompletedHealthy VolunteersGermany
-
University of Campinas, BrazilCompletedEnd-stage Renal DiseaseBrazil
-
AstraZenecaBristol-Myers SquibbCompletedType 1 Diabetes MellitusUnited States, Austria, Germany, Italy, Spain, United Kingdom, Belgium, Mexico, Israel, Hungary, Canada, Australia, Denmark, Sweden, Romania, France, Finland
-
AstraZenecaAstra Zeneca, Bristol-Myers SquibbCompletedType 1 Diabetes MellitusUnited States
-
Pharma NuevaNot yet recruiting
-
Kasr El Aini HospitalCompleted
-
The Deutsche Diabetes Forschungsgesellschaft e.V.Novo Nordisk A/S; Boehringer Ingelheim; Federal Ministry of Health, Germany; German... and other collaboratorsRecruitingType 2 Diabetes | Non-alcoholic Fatty Liver Disease (NAFLD) | Non-alcoholic Steatohepatitis (NASH)Germany, Austria
-
University of RochesterAstraZenecaCompleted
-
Mansoura UniversityActive, not recruitingLupus Nephritis | BMD | SGLT2 INHIBITORSEgypt
-
AstraZenecaParexel; PRA Health Sciences; Q2 Solutions; Covance Laboratories, IncCompletedType 2 DiabetesUnited States, Israel, Hungary, Russian Federation, Mexico, Romania, United Kingdom
-
E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd.Not yet recruiting
-
Alexandria UniversityCompleted
-
University Medical Center GroningenAstraZenecaEnrolling by invitationChronic Kidney DiseasesNetherlands, Canada, United States, Denmark, United Kingdom
-
AstraZenecaBristol-Myers SquibbCompleted
-
University of Colorado, DenverRecruitingVascular Diseases | Diabetes | Kidney Transplant; ComplicationsUnited States
-
University of OklahomaRecruitingDiabetes Mellitus | Atrial FibrillationUnited States
-
RenJi HospitalRecruitingHemodialysis ComplicationChina
-
Andrea GiaccariRecruitingType2 Diabetes Mellitus | Stable Coronary Artery DiseaseItaly
-
University of PennsylvaniaAmgenCompleted
-
Mansoura UniversityCompletedAcute Heart FailureEgypt
-
Postgraduate Institute of Medical Education and...CompletedPancreatic LipomatosisIndia
-
CHEOL WHAN LEE, M.D., Ph.DTerminatedCoronary Artery Disease | Prediabetic StateKorea, Republic of
-
Yonsei UniversityCompletedType 2 Diabetes MellitusKorea, Republic of
-
AstraZenecaBristol-Myers SquibbCompleted